Ademco – SG

Combating Counterfeit Pharmaceuticals: A Multifaceted Approach for Manufacturers

Counterfeit pharmaceuticals pose a serious global health threat. The World Health Organization (WHO) estimates 10-15% of medicines in low- and middle-income countries are fake, rising to 50% in some regions. The Pharmaceutical Security Institute (PSI) reported over 1,500 counterfeit drug incidents in 2022 alone. These counterfeits have tragic consequences, including loss of life, inflated healthcare costs, and eroded trust in healthcare systems. To combat this issue, pharmaceutical manufacturers must adopt a multifaceted strategy that integrates advanced technologies, robust security measures, and strict regulatory compliance.

 

How Counterfeit Products Enter the Market: Exploiting Vulnerabilities

Counterfeit pharmaceuticals infiltrate the market through various channels, exploiting weaknesses in the pharmaceutical supply chain, particularly during manufacturing and distribution. Counterfeiters may introduce fake drugs disguised as genuine products, making it difficult to distinguish authenticity.

Manufacturing and Distribution Weaknesses:

Non-Conforming Packaging: Flawed packaging materials can be used by counterfeiters to create near-identical replicas of genuine products.
Prototypes: Improper disposal of prototypes during drug or packaging design creates opportunities for counterfeiting.
Rejected or Returned Products: Improperly accounted for or destroyed authentic packaging from rejected or returned pharmaceuticals can be used to house counterfeit drugs.

 

Securing the Pharmaceutical Manufacturing and Supply Chain Process: A Multi-Layered Approach

To safeguard against counterfeit pharmaceuticals and prioritize patient safety, pharmaceutical manufacturers must implement robust security measures throughout their operations.  In order to prevent counterfeits from entering the legitimate supply chain, organizations need to understand and integrate technologies such as access control and video surveillance into the design of the manufacturing process flow with the correct quality control procedures and incident response protocols.

  • Strict Access Controls: Only authorized personnel are granted access to critical areas and materials, minimizing the risk of tampering or theft. This includes ensuring only authorized personnel and escorted visitors have access to products, while external visitors are identified using government-issued ID. Outsourced workers are prohibited from entering internal areas and provided with designated waiting areas.
  • 24/7 Video Surveillance: Areas where pharmaceutical products are manufactured and stored are under constant video surveillance, from production to shipping and receiving, including entry and exit points. Coverage extends to external loading/unloading areas and facility perimeters with advanced camera systems featuring motion detection and facial recognition.
  • Advanced Tracking Technologies: Tracking technologies like serialization and tamper-evident packaging allow for better visibility and verification of products throughout the supply chain. Integrating geolocation and geofencing can further enhance fleet monitoring capabilities.

     

The First Line of Defense: Advanced Access Control Systems

The cornerstone of security lies in securing physical access to manufacturing and storage facilities. Implementing advanced access control systems, such as biometric scanners utilizing fingerprints or facial recognition, grants entry only to authorized personnel. These systems offer superior reliability compared to traditional key cards. Integrating RFID tags and smart cards provides real-time tracking of personnel movement within the facility, coupled with surveillance-backed body search protocols, ensuring no contraband or stolen items enter or exit.

  • Enhanced Security: Biometric verification significantly reduces the risk of unauthorized access.
  • Real-Time Tracking: RFID tags and smart cards allow for tracking personnel movement, providing valuable data for security purposes.
  • Improved Accountability: Knowing exactly who entered and exited the facility enhances accountability and deters theft or misconduct.
  • Body Search Protocols: Well-defined body search protocols further deter the entry or removal of contraband or stolen items.

Regulatory bodies also enforce strict GMP regulations, requiring layered access controls for manufacturing facilities, including physical and logical security measures.

 

Continuous Monitoring with AI-Enhanced Surveillance

Continuous monitoring through high-definition video surveillance equipped with AI capabilities plays a vital role. By integrating these cameras with alarm systems and a Central Monitoring and Command Center (CMCC), these intelligent systems go beyond simple recording:

  • AI-powered Analytics: The system analyzes the video stream in real-time, identifying suspicious behaviors like unauthorized access attempts, loitering in sensitive areas, or unauthorized personnel movement. Additionally, it can be programmed to recognize specific objects, triggering alerts if detected.
  • Real-Time Alerts and Response: Upon detecting suspicious activity, the AI system triggers immediate alerts:
    • Security personnel stationed within the facility are notified for prompt investigation.
    • The CMCC receives real-time notifications, allowing for situation assessment, coordinated response efforts, and security personnel dispatch if necessary.
  • 24/7 Monitoring and Situational Awareness: The CMCC acts as the central hub, providing 24/7 monitoring of all cameras across the facility. Real-time access to video feeds allows security personnel to maintain complete situational awareness and proactively respond to potential threats.
  • Integration with Alarm Systems: AI-powered video surveillance can be seamlessly integrated with existing security alarm systems. When suspicious activity is detected, the system can trigger alarms in the vicinity, further deterring intruders and alerting personnel.

     

Securing the Supply Chain with Tracking Technology

The pharmaceutical supply chain presents a vulnerability for the introduction of counterfeit drugs. Advanced tracking technologies like RFID and GPS can significantly mitigate these risks. Additionally, automating license plate and container ID recognition ensures only authorized vehicles enter and exit the premises.

A Central Monitoring and Command Center (CMCC) can further enhance security by integrating data from various sources, including video surveillance, access control systems, and tracking technologies.

  • RFID Tags: Attaching Radio Frequency Identification (RFID) tags to product packages allows for real-time tracking throughout the supply chain. These tags emit a unique signal that can be read by scanners at designated checkpoints, providing a transparent record of a product’s journey. This real-time visibility ensures products remain secure and uncompromised, deterring potential tampering or diversion.
  • GPS Tracking for Vehicles: Equipping transport vehicles with GPS tracking devices allows for constant monitoring of their location and adherence to designated routes and schedules. Any deviation from the planned route can trigger an immediate alert at the Central Monitoring and Command Center (CMCC), enabling swift investigation and potential intervention to prevent stolen goods or unauthorized stops.
  • Geofencing for Enhanced Security: Virtual perimeters, or geofences, can be established around critical locations within the supply chain, such as warehouses, distribution centers, or designated rest stops. When a GPS-enabled vehicle enters or exits a geofence, the CMCC receives an instant notification. This allows for real-time monitoring of authorized movement and immediate detection of any unauthorized entry or exit attempts, significantly reducing the risk of theft or product diversion.

     

Maintaining Security Through Regular Audits

Even the most advanced security systems require ongoing vigilance. Regular audits and inspections are essential for identifying and addressing vulnerabilities within the manufacturing process and supply chain. Here’s how they contribute to a robust security posture:

  • Surprise Audits and Random Inspections: These can unearth potential security breaches that might go unnoticed in routine checks. Unannounced inspections keep staff vigilant and deter insider threats.
  • Compliance Checks: Audits ensure adherence to all regulatory standards, including GMP guidelines. This minimizes the risk of non-compliance penalties and ensures the security measures implemented meet the specific requirements of the pharmaceutical industry.

     

Conclusion

By implementing a multi-layered security approach that combines these strategies, pharmaceutical manufacturers can significantly reduce the risk of counterfeit drugs entering the supply chain, thereby safeguarding public health and ensuring patient safety.

Like our post? Share it!
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Contact Us